drugset / Trial / NCT03744104
A Clinical Trial of A Quadrivalent Influenza Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of this study is to assess the immunogenicity and safety of a quadrivalent influenza vaccine compared with a trivalent influenza vaccine in participants aged above 3 years.
Timeline
- Start
- 2018-10-11
- Primary completion
- 2019-10-08
- Completion
- 2019-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quadrivalent influenza vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Trivalent influenza vaccine A | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Trivalent influenza vaccine B | Vaccine | 0.5 ml | Intramuscular |